SpectrumX proudly announces the acquisition of its licence, to manufacture and distribute Medicinal Specials, from the Medicines and Healthcare products Regulatory Agency (MHRA). This achievement underscores SpectrumX’s dedication to delivering safe and effective GMP (Good Manufacturing Practice)-compliant healthcare solutions. GMP is the level of compliance major pharmaceuticals companies operate to, and now SpectrumX will be operating at this level.
This MHRA licence enables SpectrumX to expand its offerings within the healthcare industry, providing cutting-edge GMP standard products designed to enhance patient well-being. With a focus on safety and efficacy, SpectrumX continues to develop and deliver high-quality solutions tailored to the unique needs of the healthcare community.
“Obtaining the MHRA licence is a testament to our dedication to excellence in healthcare,” said Damien Hancox, CEO of SpectrumX. “We are excited to contribute to the healthcare community and support the health and well-being of patients across the UK and, in due course, internationally.”
SpectrumX’s state-of-the-art production facility in Knutsford, Cheshire, is equipped with advanced clean rooms, ensuring the highest standards in manufacturing and product development.
